• 
  Marion Berdal, Sébastien Gouard, Romain Eychenne, Séverine Marionneau-Lambot, Mikaël Croyal, et al.. Investigation on the reactivity of nucleophilic radiohalogens with arylboronic acids in water: access to an efficient single-step method for the radioiodination and astatination of antibodies. Chemical Science , The Royal Society of Chemistry, 2020, Online ahead of print. ⟨10.1039/D0SC05191H.⟩. ⟨inserm-03024891⟩
• 
  Fabien Vidal, Paul Guerby, Mathieu Luyckx, Pascale Haddad, Eberhard Stoeckle, et al.. Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?. PLoS ONE, Public Library of Science, 2016, 11 (1), pp.e0147787. ⟨10.1371/journal.pone.0147787⟩. ⟨inserm-02940269⟩
• 
  Clément Palpacuer, Karima Hammas, Renan Duprez, Bruno Laviolle, John P A Ioannidis, et al.. Vibration of effects from diverse inclusion/exclusion criteria and analytical choices 9216 different ways to perform an indirect comparison meta-analysis. BMC Medicine, BioMed Central, 2019, 17 (1), pp.174. ⟨10.1186/s12916-019-1409-3⟩. ⟨hal-02304653⟩
• 
  R Da-Ano, Ingrid Masson, Felix Lucia, M. Dore, Patrice Robin, et al.. Performance comparison of modified ComBat for harmonization of radiomic features for multicenter studies. Scientific Reports, Nature Publishing Group, 2020, 10 (1), pp.10248. ⟨10.1038/s41598-020-66110-w⟩. ⟨hal-02887419⟩
• 
  Emmanuelle Bompas, Loïc Campion, Antoine Italiano, Axel Le Cesne, Christine Chevreau, et al.. Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study. Cancer Medicine, Wiley, 2018, Cancer medicine, 7 (8), pp.4023-4035. ⟨10.1002/cam4.1374⟩. ⟨hal-01978221⟩
• 
  Loic Lebellec, François Bertucci, Emmanuelle Tresch-Bruneel, Emmanuelle Bompas, Yves Toiron, et al.. Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO). Oncotarget, Impact journals, 2016, Oncotarget, 7 (45), pp.73984-73994. ⟨10.18632/oncotarget.12172⟩. ⟨hal-01453300⟩
• 
  Pauline Rochefort, Antoine Italiano, Valérie Laurence, Nicolas Penel, Audrey Lardy-Cleaud, et al.. A retrospective multicentric study of ewing sarcoma family of tumors in patients older than 50: management and outcome. Scientific Reports, Nature Publishing Group, 2017, Scientific reports, 7, ⟨10.1038/s41598-017-17733-z⟩. ⟨hal-02613645⟩
• 
  Elodie Girard, Séverine Eon‐marchais, Robert Olaso, Anne‐laure Renault, Francesca Damiola, et al.. Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing. International Journal of Cancer, Wiley, 2019, 144 (8), pp.1962-1974. ⟨10.1002/ijc.31921⟩. ⟨inserm-02438452⟩
• 
  Marion Couderc, Anne Tournadre, Sylvain Mathieu, Bruno Pereira, Martin Soubrier, et al.. Do the salivary glands of patients with systemic sclerosis show ultrasonographic modifications suggestive of Sjögren's syndrome?. Annals of the Rheumatic Diseases, BMJ Publishing Group, 2019, pp.annrheumdis-2019-215777. ⟨10.1136/annrheumdis-2019-215777⟩. ⟨hal-02343567⟩
• 
  Christophe Le Tourneau, Maud Kamal, Olivier Trédan, Jean-Pierre Delord, Mario Campone, et al.. Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial. Targeted Oncology, Springer Verlag (Germany), 2012, 7 (4), pp.253-265. ⟨10.1007/s11523-012-0237-6⟩. ⟨inserm-02294308⟩
• 
  Flora Goupy, Stephane Supiot, David Pasquier, Igor Latorzeff, Ulrike Schick, et al.. Intensity-modulated radiotherapy for prostate cancer with seminal vesicle involvement (T3b) A multicentric retrospective analysis. PLoS ONE, Public Library of Science, 2019, 14 (1), pp.e0210514. ⟨10.1371/journal.pone.0210514⟩. ⟨hal-02049134⟩
• 
  L. Berger, Guillaume Boissonnat, H. Chesneau, V. Passal, J. Desrousseaux, et al.. IGRT kV-imaging dose MC calculations validated in anthropomorphic phantoms using OSL. ESTRO 37 - European SocieTy for Radiotherapy & Oncology, Apr 2018, Barcelona, Spain. Radiotherapy and Oncology, 127 (Supplement 1), S1004-S1005; poster EP-1860, 2018, ESTRO 37, April 20-24, 2018, Barcelona, Spain. ⟨10.1016/S0167-8140(18)32169-8⟩. ⟨hal-01878965⟩
• 
  Raphael Leman, Pascaline Gaildrat, Gerald L. Gac, Chandran Ka, Yann Fichou, et al.. Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort. Nucleic Acids Research, Oxford University Press, 2018, 46 (15), pp.7913-7923. ⟨10.1093/nar/gky372⟩. ⟨hal-01910334⟩
• 
  Sandrine Caputo, Mélanie Léoné, Francesca Damiola, Asa Ehlen, Aura Carreira, et al.. Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer. Oncotarget, Impact journals, 2018, 9 (9), pp.17334-17348. ⟨10.18632/oncotarget.24671⟩. ⟨hal-01928011⟩
• 
  Samuel Golten, Allan Patinec, Katy Akoumany, Jézabel Rocher, Jérôme Graton, et al.. 3,4-Dideoxy-3,3,4,4-tetrafluoro-and 4-OH 1 Epimeric 3-Deoxy-3,3-difluoro--GalCer 2 Analogues: Synthesis and Biological Evaluation 3 on Human iNKT Cells Stimulation. 4. European Journal of Medicinal Chemistry, Elsevier, In press. ⟨inserm-02140266⟩
• 
  Pascal Jézéquel, Olivier Kerdraon, Hubert Hondermarck, Catherine Guérin-Charbonnel, Hamza Lasla, et al.. Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications. Breast Cancer Research, BioMed Central, 2019, 21 (1), pp.65. ⟨10.1186/s13058-019-1148-6⟩. ⟨inserm-02140196⟩
• 
  Céline Mirjolet, Jean-Louis Merlin, Gilles Truc, Georges Noël, Juliette Thariat, et al.. RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study. EBioMedicine, Elsevier, 2019, 41, pp.420-426. ⟨10.1016/j.ebiom.2019.02.031⟩. ⟨hal-02110945⟩
• 
  A. Keller, M. Doré, D. Antoni, I. Menoux, F. Thillays, et al.. Risque de radionécrose après radiothérapie hypofractionnée en conditions stéréotaxiques du lit opératoire de métastases cérébrales. Cancer Radiothérapie, Elsevier Masson, 2017, 21 (5), pp.377-388. ⟨10.1016/j.canrad.2017.01.017⟩. ⟨inserm-01982313⟩
• 
  Pascal Jézéquel, Delphine Loussouarn, Catherine Guérin-Charbonnel, Loïc Campion, Antoine Vanier, et al.. Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response. Breast Cancer Research, BioMed Central, 2015, 17, pp.43. ⟨10.1186/s13058-015-0550-y⟩. ⟨inserm-01820311⟩
• 
  Pascal Jézéquel, Zein Sharif, Hamza Lasla, Wilfried Gouraud, Catherine Guérin-Charbonnel, et al.. Gene-expression signature functional annotation of breast cancer tumours in function of age. BMC Medical Genomics, BioMed Central, 2015, 8, pp.80. ⟨10.1186/s12920-015-0153-6⟩. ⟨inserm-01819788⟩

38

103